Stocks and Investing Stocks and Investing
Thu, February 16, 2017

Christopher James Initiated (BCRX) at Strong Buy and Held Target at $11 on, Feb 16th, 2017


Published on 2024-10-25 20:15:57 -
  Print publication without navigation


Christopher James of Ladenburg Thalmann, Initiated "BioCryst Pharmaceuticals, Inc." (BCRX) at Strong Buy and Held Target at $11 on, Feb 16th, 2017.

Christopher, nor any peers, have made any analyst calls on BCRX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30